Storia della carriera di Jon Davies
Precedenti posizioni note di Jon Davies
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| HORIZON DISCOVERY GROUP PLC | Contatto Relazioni con gli Investitori | 01/04/2019 | 01/09/2021 |
Xenova Group Plc
 Xenova Group Plc Miscellaneous Commercial ServicesCommercial Services Xenova Group Plc researches and develops pharmaceutical products. The company is focused on the development of novel drugs to treat cancer and addiction with a secondary focus in immunotherapy. It has pipeline of drug candidates in clinical development including a novel program for the treatment of high-grade glioma and TransMID. The company was founded in 1987 and is headquartered in Slough, UK | Contatto Relazioni con gli Investitori | - | - |
| Public Communications Contact | - | - | |
| DATATEC LIMITED | Contatto Relazioni con gli Investitori | - | - |
| Public Communications Contact | - | - | |
| TOUCHSTONE INNOVATIONS PLC | Contatto Relazioni con gli Investitori | 01/01/2014 | - |
| Public Communications Contact | 01/01/2014 | - |
Formazione di Jon Davies
| University of Sussex | Doctorate Degree |
| University of London | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Regno Unito | 6 |
| Sud Africa | 2 |
Posizioni
| Investor Relations Contact | 4 |
| Public Communications Contact | 3 |
| Doctorate Degree | 1 |
Settori
| Consumer Services | 3 |
| Finance | 2 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| DATATEC LIMITED | Technology Services |
| Aziende private | 3 |
|---|---|
Touchstone Innovations Ltd.
 Touchstone Innovations Ltd. Investment ManagersFinance Touchstone Innovations Ltd. engages in the provision of technology and commercialization services. The company was founded by Susan Jane Searle in 1986 and is headquartered in London, the United Kingdom. | Finance |
Xenova Group Plc
Xenova Group Plc Miscellaneous Commercial ServicesCommercial Services Xenova Group Plc researches and develops pharmaceutical products. The company is focused on the development of novel drugs to treat cancer and addiction with a secondary focus in immunotherapy. It has pipeline of drug candidates in clinical development including a novel program for the treatment of high-grade glioma and TransMID. The company was founded in 1987 and is headquartered in Slough, UK | Commercial Services |
Horizon Discovery Group Ltd.
 Horizon Discovery Group Ltd. Medical SpecialtiesHealth Technology Horizon Discovery Group Ltd. is a cell engineering company, which engages in the design and engineering of genetically-modified cells. The firm operates through the following business segments: Products, Services, and Leveraged Research & Development. The Products segment sells cell lines and other products. The Services segment offers cell line manufacturing services. The Leveraged Research & Development segment business unit is operated on a portfolio basis. It serves pharmaceutical, biotechnology, and diagnostic companies. The company was founded by Christopher John Torrance, Adam John Collier, and Alberto Bardelli in July 2005 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Jon Davies
- Esperienza
